• ̍̍ CSE: BRAX
  • ̍̍ OTC: BRAXF
  • ̍̍ FWB: 4960


October 25, 2021

W5: Harnessing the Power of Psychedelic Drug Therapy

A W5 investigation into an unconventional treatment for severe depression and PTSD that involves the drug ketamine.

October 14, 2021

NBA Champion Lamar Odom

Braxia Scientific CEO Dr. Roger McIntyre to Share Stage With NBA Champion Lamar Odom and ‘Psychedelic Concierge’ Zappy Zapolin to Discuss the Benefits of Ketamine Treatment for Mental Health Panel discussion on November 9 at Wonderland: Miami will review the benefits of ketamine treatment for depression and other mental health conditions TORONTO, ONTARIO October 14, 2021 – Braxia Scientific Corp. (“Braxia”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disorders, is pleased to announce its CEO, Dr. Roger McIntyre, will join fellow VIPs Lamar Odom and Zappy Zapolin for a panel discussion entitled “Ketamine Treatment Goes Mainstream” at the Wonderland: Miami conference on November 9, 2021. The two-day event, which is scheduled to begin November 8 at the Adrienne Arsht Center for the Performing...

July 4, 2021

VeraCity: The Psychedelic Frontier

VeraCity: The Psychedelic Frontier aired January 25 on Citytv. Dr. McIntyre speaks about research and treatments.